Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Palbociclib Alone and in Combination in Patients With Relapsed and Refractory Leukemias

NCT03132454 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03132454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03132454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Palbociclib Alone and in Combination in Patients With Relapsed and Refractory Leukemias
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
July 25, 2017
Completion date
December 31, 2027
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent acute lymphoblastic leukemia, recurrent acute myeloid leukemia, refractory acute lymphoblastic leukemia, refractory acute myeloid leukemia